Cargando…
Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases
Autores principales: | Lauko, Adam, Kotecha, Rupesh, Barnett, Addison, Li, Hong, Tatineni, Vineeth, Ali, Assad, Patil, Pradnya, Mohammadi, Alireza M., Chao, Samuel T., Murphy, Erin S., Angelov, Lilyana, Suh, John H., Barnett, Gene H., Pennell, Nathan A., Ahluwalia, Manmeet S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763914/ https://www.ncbi.nlm.nih.gov/pubmed/35039661 http://dx.doi.org/10.1038/s41598-022-05489-0 |
Ejemplares similares
-
Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases
por: Lauko, Adam, et al.
Publicado: (2021) -
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases
por: Lauko, Adam, et al.
Publicado: (2021) -
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases
por: Lauko, Adam, et al.
Publicado: (2022) -
THER-09. IMPACT OF KRAS MUTATION STATUS ON THE EFFICACY OF IMMUNOTHERAPY IN LUNG CANCER BRAIN METASTASES
por: Lauko, Adam, et al.
Publicado: (2019) -
Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases
por: Lauko, Adam, et al.
Publicado: (2021)